Cornerstone Advisors (Washington)’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $1K | Buy |
36
+12
| +50% | +$333 | ﹤0.01% | 690 |
|
|
2020
Q2 | $1K | Sell |
24
-11
| -31% | -$458 | ﹤0.01% | 683 |
|
|
2020
Q1 | $1K | Buy |
+35
| New | +$1K | ﹤0.01% | 712 |
|
|
2019
Q3 | – | Sell |
-813
| Closed | -$27K | – | 1301 |
|
|
2019
Q2 | $27K | Buy |
813
+74
| +10% | +$2.46K | ﹤0.01% | 580 |
|
|
2019
Q1 | $26K | Sell |
739
-14
| -2% | -$493 | ﹤0.01% | 545 |
|
|
2018
Q4 | $25K | Hold |
753
| – | – | ﹤0.01% | 463 |
|
|
2018
Q3 | $38K | Hold |
753
| – | – | 0.02% | 381 |
|
|
2018
Q2 | $45K | Hold |
753
| – | – | 0.03% | 327 |
|
|
2018
Q1 | $34K | Buy |
753
+14
| +2% | +$632 | 0.02% | 377 |
|
|
2017
Q4 | $29K | Hold |
739
| – | – | 0.02% | 406 |
|
|
2017
Q3 | $30K | Sell |
739
-292
| -28% | -$11.9K | 0.02% | 392 |
|
|
2017
Q2 | $44K | Hold |
1,031
| – | – | 0.02% | 304 |
|
|
2017
Q1 | $32K | Hold |
1,031
| – | – | 0.02% | 377 |
|
|
2016
Q4 | $26K | Hold |
1,031
| – | – | 0.02% | 414 |
|
|
2016
Q3 | $25K | Hold |
1,031
| – | – | 0.02% | 413 |
|
|
2016
Q2 | $21K | Hold |
1,031
| – | – | 0.02% | 277 |
|
|
2016
Q1 | $16K | Hold |
1,031
| – | – | 0.02% | 324 |
|
|
2015
Q4 | $14K | Hold |
1,031
| – | – | 0.02% | 383 |
|
|
2015
Q3 | $14K | Buy |
+1,031
| New | +$14K | 0.01% | 388 |
|